MANILA, Dec 23 (Mabuhay) –The Food and Drug Administration (FDA) on Thursday granted emergency use authorization (EUA) to anti-COVID-19 drug molnupiravir.

FDA Director General Eric Domingo said this drug will be used on patients with mild to moderate COVID-19.

“This can only be given to adults aged 18 and above, who tested positive for COVID-19 and are at risk of developing severe illness,” Domingo said during the Laging Handa briefing.

“Molnupiravir is given twice a day for five days, but should be given as soon as possible after diagnosis. And it should be given within the first five days after the onset of symptoms,” he added.

An EUA allows legal administration of the drug in the country but does not allow for commercial selling. (MNS)

READ NEXT: World Bank OKs add’l $300-M loan for Philippines’ vaccination drive